Trial Profile
Phase I trial of S 47445 for the treatment of Alzheimer's disease and other memory and cognitive impairments associated with neurodegenerative disorders
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Oct 2011
Price :
$35
*
At a glance
- Drugs Tulrampator (Primary)
- Indications Alzheimer's disease; Cognition disorders; Memory disorders
- Focus Adverse reactions
- 06 Oct 2011 Status changed from planning to completed.
- 12 Nov 2010 New trial record